MOBILE VIEW  | 
Sort by

FANOLESOMAB

Detailed evidence-based information

GOLIMUMAB

Detailed evidence-based information

IBRITUMOMAB TIUXETAN

Detailed evidence-based information

INFLIXIMAB

Detailed evidence-based information

INOLIMOMAB

Detailed evidence-based information

IPILIMUMAB

Detailed evidence-based information

IXEKIZUMAB

Detailed evidence-based information

MEPOLIZUMAB

Detailed evidence-based information

MUROMONAB-CD3

Detailed evidence-based information

NATALIZUMAB

Detailed evidence-based information
Previous 1 2 3 4 5 Next ... Last